Published 07/03/2009 by FT Alphaville
J&J to buy stake in Ireland’s Elan
Johnson & Johnson on Thursday said it will buy an 18.4% stake in Irish biotech company Elan, in a $1.5bn bid to crack the elusive but potentially lucrative market for Alzheimer's disease treatments, reports the WSJ. The agreement gives J&J access to bapineuzumab, a closely watched...
Share this
There are no more reports on this story yet.